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1. Introduction 
The Ltype pyruvate kinase (EC 2.7.1.40) from rat 
liver is an allosteric enzyme and its activity can be 
modulated to a great extent by various allosteric 
effecters [ 1 ] . The most important allosteric inhibitors 
are alanine and ATP, while Fru-1,6-P, is the most 
important activator. To describe the various allosteric 
interactions of the L-type, a model has been developed 
by Rozengurt et al. [2] which is based upon the 
allosteric model of Monod et al. [3]. This model 
predicts the existence of two unique conformational 
states. The R state is introduced by the activator 
Fru-1,6-P,, H’ ions, K’ ions and high P-enolpyruvate 
concentrations, while the T state is stabilized by the 
inhibitors ATP and alanine. Recent evidence has shown 
that Fru-1 ,6-P2 and K’ ions induce a different 
conformational state rather than one unique R state 
[4]. From kinetic studies we concluded earlier [5] 
that alanine and ATP each introduce a different T 
conformation probably by binding to different sites. 
The here reported thermostability experiments support 
this interpretation and it can be concluded that 
sequential conformation changes [6] are involved in 
the allosteric transitions of the enzyme. 
2. Materials and methods 
Ltype pyruvate kinase was isolated from rat liver 
according to the isolation procedure described earlier 
[51* 
Stability experiments were performed at 53.0°C. 
The incubation mixture contained 0.25 M Tris-HCl 
pH 7.5,5 mM reduced glutathione (GSH), 50 mM 
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creatine-P and 0.1 mg creatine-P-kinase (EC 2.7.3.2). 
The total incubation volume was 1 .O ml containing 
precisely 6.5 mg protein. Samples were taken at the 
times indicated in the figures and immediately assayed 
for pyruvate kinase activity. The reaction mixture 
contained 1 mM ADP, 1 mM P-enolpyruvate, 0.5 mM 
Fru-1,6-P,, 5 mM GSH, 225 mM KCl, 25 mM 
MgCla ,2 mM EDTA, 0.12 mM NADH, 0.1 mg lactate 
dehydrogenase and 25 mM Tris-HCl pH 7.5. To 
exclude effector changes during the incubation time 
at 53.O“C the reactions were stopped after 1 hr 
incubation with 5% perchloric acid. The effector 
concentrations were determined by standard procedures 
[7]. No significant changes were determined in the 
effector concentrations during the incubation procedure 
when compared to zero times. 
3. Results 
In fig.1 is plotted the effect of increasing alanine 
concentrations on the stability of the Ltype pyruvate 
kinase at 53.O’C. It can be observed that alanine 
stabilizes the enzyme with a maximal effect at 10 mM 
alanine. A further increase in alanine concentration 
does not improve the thermostability of the enzyme. 
The semilogarithmic plot of the % activity vs time 
(fig.1 B) shows biphasic curves, indicative for two 
pseudo first-order inactivation steps. Such a biphasic 
inactivation behaviour is also found for yeast pyruvate 
kinase [8,9] . 
Figs. 2A and 2B show that the effect of ATP on the 
Ltype pyruvate kinase from rat liver is similar to the 
effect of alanine. Increasing concentrations of ATP 
stabilize the enzyme and a maximum stabilization 
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Fig.lA, B. Influence of increasing alanine concentrations on the stability of L-type pyruvate kinase at 53.O”C. (o---o) control. 
(m--m) 1 mM Ala. (A-A) 5 mM Ala. (A---A) 10 mM Ala. (n----o) 15 mM Ala. 
% activitv 
00 
0 IO 20 40 60 
min 
log (% activity) 
B 
1.0 
I I 
0 
I 
10 20 
I 
40 60 
min 
FWA, B. Influence of increasing ATP concentrations on the stability of L-type pyruvate kinase at 53.O”C. (O-O) control. 
(m---m) 1 mM ATP. (A-A) 5 mM ATP. (A---A) 10 mM ATP. (o---n) 15 mM ATP. 
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Fig.3A, B. Influence of increasing ATP concentrations on the stability of L-type pyruvate kinase at 53.O”C in the presence of 
10 mM ahmine. (o-0) 10 mM Ala. (A-A) 10 mM Ala + 1 mM ATP. (o-o) 10 mM Ala + 5 mM ATP. (o-0) 10 mM Ala + 
10 mM ATP. 
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FigAA, B. Influence of increasing alanine concentrations on the stability of L-type pyruvate kinase at 53.O”C in the presence of 
10 mM ATP. (o---o) 10 mM ATP. (A-A) 10 mM ATP + 1 mM Ala. (0-0) 10 mM ATP + 5 mM Ala. (0-o) 10 mM ATP + 
10 mM Ala. 
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Fig.SA, B. Influence of ATP and alanine on the stability of L-type pyruvate kinase at 53.O”C in the absence and presence of 1 mM 
Fru-1,6-P,. (P--O) 10 mM ATP. (m-m) 10 mM ATP + 1 mM Fru-1,6-P,. (P-O) 10 mM Ala. (o-o) 10 mM Ala + 1 mM Fru-1,6- 
P 2’ 
occurs at 10 mM ATP. Also in the presence of ATP 
the semilogarithmic plot (fig.2B) is biphasic. However, 
the extent of maximal stabilization with ATP is lower 
than with alanine. With the five different preparations 
of Ltype pyruvate kinase tested, it was found that the 
residual activity after incubation for 60 min with 
alanine (10 mM) was at least 10% higher than after 
incubation with ATP (10 mM). This difference in 
stability is indicative for different conformations, at 
least under the conditions used. 
Figs. 3A and 3B show that addition of ATP to the 
maximally alanine (10 mM) - stabilized enzyme 
results in a further stabilization. The same phenomenon 
occurs when alanine is added to the enzyme which is 
maximally stabilized by ATP (figs. 4A and 4B). Also 
in the presence of both alanine and ATP the semilo- 
garithr-nic plot is biphasic which indicates that the 
order of inactivation does not change. From figs. 3 and 
4 we can conclude that the alanine-stabilized enzyme 
can be converted by ATP into a conformation (and 
vice versa) which is even more stable, suggesting that 
alanine and ATP do not stabilize one unique T 
conformation as predicted by the model of Monod 
et al. [3]. 
Figs. 5A and 5B show that also in the presence of 
the allosteric activator Fru-1,6-P, [ 10,l I] the effects 
of ATP and alanine are not similar. Fru-1,6-Ps labilizes 
the Ltype pyruvate kinase in the same way 
(unpublished) as has been shown earlier for the yeast 
enzyme [8,9]. Fig.5 shows that also in the presence of 
alanine or ATP addition of Fru-I ,6-P* results in a 
strong labilization of the enzyme. The loss of activity 
in the presence of ATP differs from that in the presence 
of alanine, indicating again that the effect of these 
compounds are not identical. 
4. Discussion 
By comparison of the effects of ATP and alanine on 
the apparent affinities of I/type pyruvate kinase for 
its allosteric activators Glc-I ,6-P,, Glc-6-P, Fru-1,6-P, 
and Frud-P, it was concluded earlier that ATP and 
alanine introduce a different conformational state, 
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probably by binding to different sites [S] . The results 
presented here support this conclusion. ATP and 
alanine both stabilize the Ltype pyruvate kinase. 
However, the degree of maximal stabilization is greater 
for alanine than for ATP. This result is difficult to 
explain by the assumption that these compounds 
stabilize one unique T conformation as predicted by 
the Monod model [3] which has been applied to the 
Ltype from liver [2] . Furthermore, figs. 3 and 4 show 
that a further stabilization occurs when ATP is added 
to the maximally alaninestabilized enzyme or vice 
versa, indicating additive effects of alanine and ATP on 
the stabilization. This indicates that ATP and alanine 
induce different conformations and bind to different 
sites on the enzyme. Fru-1,6-P, labilizes the enzyme, 
an effect which can be expected from an allosteric 
activator which normally decrease the interaction 
between the subunits. However, also in the presence of 
Fru-1,6-P* the effects of alanine and ATP are different. 
Rozengurt et al. [4] recently showed that the allosteric 
activators K’ and Fru-1 ,6-PZ each induce a different 
R conformation. Our data indicate that also different 
T conformations are possible. These results, together 
with the earlier obtained kinetic data,[5] are difficult 
to explain with the two state model of Monod et al. [3] 
and indicate that sequential conformation changes [6] 
are involved in the allosteric transitions of this enzyme. 
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